Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Boston Scientific Corp (BSX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 35,304,968
  • Shares Outstanding, K 1,373,200
  • Annual Sales, $ 8,386 M
  • Annual Income, $ 347,000 K
  • 36-Month Beta 0.96
  • Price/Sales 4.19
  • Price/Cash Flow 14.71
  • Price/Book 4.61

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.54 +4.40%
on 12/06/17
28.88 -11.29%
on 11/21/17
-2.70 (-9.53%)
since 11/14/17
3-Month
24.54 +4.40%
on 12/06/17
29.93 -14.40%
on 10/23/17
-3.35 (-11.56%)
since 09/14/17
52-Week
21.03 +21.83%
on 12/15/16
29.93 -14.40%
on 10/23/17
+4.41 (+20.79%)
since 12/14/16

Most Recent Stories

More News
Whistleblower Defeats Motion To Dismiss In Lawsuit Alleging Defective Defibrilators

Late yesterday, Judge Joan N. Ericksen denied in its entirety Boston Scientific Corporation's motion to dismiss a whistleblower lawsuit involving allegedly defective cardiac defibrillators. The case will...

BSX : 25.62 (-0.35%)
Cibiem Appoints William H. Kucheman to the Board of Directors

Cibiem, Inc., a clinical-stage medical device company targeting the carotid body to treat diseases like hypertension and heart failure, today announced that industry veteran William H. (Hank)...

BSX : 25.62 (-0.35%)
US Benign Prostatic Hyperplasia (BPH) Procedures Analysis and Forecast to 2023: Key Players are NxThera, Inc., Boston Scientific Corporation, Urologix, LLC., Convergent Laser Technologies - Research and Markets

The "US Benign Prostatic Hyperplasia (BPH) Procedures Analysis and Forecast to 2023" report has been added to Research and Markets' offering.

BSX : 25.62 (-0.35%)
Arterial Stents Market Value to Reach US$17.8 Billion by the End of 2025: Transparency Market Research

Due to the presence of several regional and global players, the vendor landscape of the global arterial stents market is fragmented. Abbott Laboratories, Cordis Corporation, Boston Scientific Corporation,...

BCR : 332.10 (+0.03%)
ABT : 54.73 (-0.60%)
BSX : 25.62 (-0.35%)
MDT : 81.83 (-0.11%)
Boston Scientific Receives FDA Nod for Vercise DBS System

Boston Scientific (BSX) forges ahead with initiatives to boost DBS portfolio under Neuromodulation business.

PETS : 44.01 (-2.31%)
BSX : 25.62 (-0.35%)
MYGN : 33.14 (-0.39%)
ALGN : 233.80 (-0.78%)
Boston Scientific Receives U.S. FDA Approval for the Vercise(TM) Deep Brain Stimulation System

Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for the Vercise(TM) Deep Brain Stimulation (DBS) System. DBS is...

BSX : 25.62 (-0.35%)
Market Trends Toward New Normal in CME Group, Trimble Navigation, Boston Scientific, Evercore, Advanced Drainage, and Novanta -- Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CME Group Inc. (NASDAQ:CME),...

EVR : 88.55 (-0.39%)
TRMB : 40.24 (-0.67%)
BSX : 25.62 (-0.35%)
CME : 150.42 (-0.78%)
NOVT : 49.65 (+0.71%)
WMS : 22.45 (-3.02%)
Boston Scientific To Participate In BMO Capital Markets Prescriptions For Success Healthcare Conference

Boston Scientific Corporation (NYSE: BSX) will participate in the BMO Capital Markets Prescriptions for Success Healthcare Conference on December 14, 2017 in New York.

BSX : 25.62 (-0.35%)
Boston Scientific (BSX) Shares Drop on LOTUS Relaunch Delay

Boston Scientific (BSX) announces a delay in deadline for the commercial return of the LOTUS Edge Aortic Valve System in Europe. Following this news, share price declines.

PETS : 44.01 (-2.31%)
BSX : 25.62 (-0.35%)
MYGN : 33.14 (-0.39%)
LMNX : 20.37 (-0.73%)
Pre-market Technical Scan on Medical Equipment Equities -- ViewRay, Accuray, MiMedx, and Boston Scientific

In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on VRAY, ARAY, MDXG, and BSX which is a click away at www.wallstequities.com/registration....

MDXG : 12.14 (+1.25%)
BSX : 25.62 (-0.35%)
ARAY : 4.45 (-2.20%)
VRAY : 8.50 (-4.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

See More

Business Summary

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting...

See More

Key Turning Points

2nd Resistance Point 26.07
1st Resistance Point 25.84
Last Price 25.62
1st Support Level 25.44
2nd Support Level 25.26

See More

52-Week High 29.93
Fibonacci 61.8% 26.53
Last Price 25.62
Fibonacci 50% 25.48
Fibonacci 38.2% 24.43
52-Week Low 21.03

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.